Literature DB >> 9486169

Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease.

M J Borel1, M S Buchowski, E A Turner, B B Peeler, R E Goldstein, P J Flakoll.   

Abstract

Basal rates of whole body protein, glucose, and lipid metabolism and resting energy expenditure (REE) were measured in eight African-American sickle cell disease (SCD) patients and in six African-American controls. Catheters were placed 1) in an antecubital vein for stable isotope infusion and 2) in a heated hand vein for arterialized venous blood. Breath and blood were collected during the last 30 min of the 2.5-h study, and REE was measured by indirect calorimetry. REE [128 +/- 5 vs. 111 +/- 1 kJ.kg fat-free mass (FFM)-1.day-1; P < 0.05 vs. controls] was 15% greater in the SCD patients. Whole body protein breakdown (5.0 +/- 0.3 vs. 3.8 +/- 0.2 mg.kg FFM-1.min-1; P < 0.05 vs. controls) and protein synthesis (4.4 +/- 0.3 vs. 3.2 +/- 0.2 mg.kg FFM-1.min-1; P < 0.05 vs. controls) were 32 and 38% greater, respectively, in the SCD patients, but whole body amino acid oxidation was similar (0.58 +/- 0.03 vs. 0.66 +/- 0.03 mg.kg FFM-1.min-1). Measures of whole body glucose and lipid metabolism were not significantly different between the groups. The additional energy required for the greater rates of whole body protein breakdown and synthesis caused by SCD contributes significantly to the observed increase in REE, suggesting that dietary energy and protein requirements are enhanced in SCD patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486169     DOI: 10.1152/ajpendo.1998.274.2.E357

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Hydroxyurea and growth in young children with sickle cell disease.

Authors:  Sohail Rana; Patricia E Houston; Winfred C Wang; Rathi V Iyer; Jonathan Goldsmith; James F Casella; Caroline K Reed; Zora R Rogers; Myron A Waclawiw; Bruce Thompson
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

2.  Dietary protein restriction impairs growth, immunity, and disease resistance in southern leopard frog tadpoles.

Authors:  Matthew D Venesky; Travis E Wilcoxen; Michelle A Rensel; Louise Rollins-Smith; Jacob L Kerby; Matthew J Parris
Journal:  Oecologia       Date:  2011-10-30       Impact factor: 3.225

3.  Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients.

Authors:  Lara B Pupim; Paul J Flakoll; John R Brouillette; Deanna K Levenhagen; Raymond M Hakim; T Alp Ikizler
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

4.  Microvascular oxygen consumption during sickle cell pain crisis.

Authors:  Carol A Rowley; Allison K Ikeda; Miles Seidel; Tiffany C Anaebere; Matthew D Antalek; Catherine Seamon; Anna K Conrey; Laurel Mendelsohn; James Nichols; Alexander M Gorbach; Gregory J Kato; Hans Ackerman
Journal:  Blood       Date:  2014-03-24       Impact factor: 22.113

5.  Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania.

Authors:  Sharon E Cox; Julie Makani; Anthony J Fulford; Albert N Komba; Deogratius Soka; Thomas N Williams; Charles R Newton; Kevin Marsh; Andrew M Prentice
Journal:  Haematologica       Date:  2011-04-01       Impact factor: 9.941

6.  Relative adrenal insufficiency in adults with sickle cell disease.

Authors:  Eugene Sobngwi; Noel Désirée Mbango; Eric Vounsia Balti; Francoise Ngo Sack; Vicky Ama Moor; Jean-Claude Mbanya
Journal:  Pan Afr Med J       Date:  2018-01-12

Review 7.  Growth and Growth hormone - Insulin Like Growth Factor -I (GH-IGF-I) Axis in Chronic Anemias.

Authors:  Ashraf T Soliman; Vincenzo De Sanctis; Mohamed Yassin; Ashraf Adel
Journal:  Acta Biomed       Date:  2017-04-28

8.  Association of sickle cell disease with anthropometric indices among under-five children: evidence from 2018 Nigeria Demographic and Health Survey.

Authors:  Mohammad Redwanul Islam; Md Moinuddin; Ayeda Ahmed; Syed Moshfiqur Rahman
Journal:  BMC Med       Date:  2021-01-15       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.